ADIPOQ and arthritic joint disease: It has not yet been determined whether adiponectin or IL-1β contributes more to the increased expression of these MMPs in arthritic joints, but the high concentration of adiponectin in joint fluids of patients with arthritis seems to contribute significantly to the joint degradation.